Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Less fluid during surgery may lead to better recovery

NCT ID NCT01424150

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether giving less fluid during major abdominal surgery helps patients recover better than giving more fluid. Over 3,000 adults having elective abdominal surgery were randomly assigned to either a restrictive (less than 2 liters per day) or liberal (about 6 liters per day) fluid plan. The main goal was to see which group had better disability-free survival up to one year after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
intravenous fluids (restrictive vs liberal protocol)
What this could lead to
If successful, this could establish a standard for how much fluid to give during major abdominal surgery, potentially reducing complications and improving recovery.
What could go wrong
This is a completed trial, so results are already known. However, the optimal fluid strategy may still depend on individual patient factors and surgical context, limiting broad applicability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

3,000 people

The number who actually took part.

Started

Jul 2013

Finished

Oct 2017

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Adults (≥18 years) undergoing elective major surgery and providing informed consent 2. All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days (for example, oesophagectomy, gastrectomy, pancreatectomy, colectomy, aortic or aorto-femoral vascular surgery, nephrectomy, cystectomy, open prostatectomy, radical hysterectomy, and abdominal incisional hernia repair) 3. At increased risk of postoperative complications, defined as at least one of the following criteria: * age ≥70 years * known or documented history of coronary artery disease * known or documented history of heart failure * diabetes currently treated with an oral hypoglycaemic agent and/or insulin * preoperative serum creatinine \>200 µmol/L (\>2.8 mg/dl) * morbid obesity (BMI ≥35 kg/m²) * preoperative serum albumin \<30 g/L * anaerobic threshold (if done) \<12 mL/kg/min * or two or more of the following risk factors: * ASA 3 or 4 * chronic respiratory disease * obesity (BMI 30-35 kg/m²) * aortic or peripheral vascular disease * preoperative haemoglobin \<100 g/L * preoperative serum creatinine 150-199 µmol/L (\>1.7 mg/dl) * anaerobic threshold (if done) 12-14 mL/kg/min Exclusion Criteria 1. Urgent or time-critical surgery 2. ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy) 3. Chronic renal failure requiring dialysis 4. Pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions 5. Liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation 6. Minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alfred Hospital

    Melbourne, Victoria, 3004, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.